The global bioprocess technology market is expected to grow at a CAGR of 8.2% during the forecast period. An increase in the funding for biopharmaceutical R&D coupled with the rising incidence of infectious and chronic diseases such as cancer and CVD are some major factors boosting the market growth. The US Department of Commerce’s National […]
